Skip to main content
logo
Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
1.240
-0.030 (-2.36%)
At close: Apr 10, 2026, 4:00 PM EDT
1.220
-0.020 (-1.61%)
After-hours: Apr 10, 2026, 6:53 PM EDT

Fate Therapeutics Revenue

In the year 2025, Fate Therapeutics had annual revenue of $6.65M, down -51.24%. Fate Therapeutics had revenue of $1.37M in the quarter ending December 31, 2025, a decrease of -26.40%.

Revenue (ttm)
$6.65M
Revenue Growth
-51.24%
P/S Ratio
21.69
Revenue / Employee
$41,280
Employees
161
Market Cap
144.17M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20256.65M-6.99M-51.24%
Dec 31, 202413.63M-49.90M-78.55%
Dec 31, 202363.53M-32.77M-34.03%
Dec 31, 202296.30M40.45M72.44%
Dec 31, 202155.85M24.41M77.66%
Dec 31, 202031.43M20.75M194.33%
Dec 31, 201910.68M5.94M125.32%
Dec 31, 20184.74M634.00K15.44%
Dec 31, 20174.11M-296.00K-6.72%
Dec 31, 20164.40M1.97M81.08%
Dec 31, 20152.43M--
Dec 31, 2014---
Dec 31, 2013971.00K-1.70M-63.63%
Dec 31, 20122.67M1.50M128.21%
Dec 31, 20111.17M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

FATE News

More News